Alex Sapir, President & CEO at Dova Pharmaceuticals, Inc. (DOVA), bought 43,400 shares at $22.83 ($991K) on 2018-08-14, disclosed to the SEC on 2018-08-15.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.83 | 21,700 | $495K | 50.0% |
| 2 | $22.83 | 21,700 | $495K | 50.0% |
| Total | $22.83 avg | 43,400 | $991K | 100% |
| Filing → |